Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of pipecolamide cas 19889-77-1 in China. Welcome to wholesale bulk high quality pipecolamide cas 19889-77-1 for sale here from our factory. Good service and reasonable price are available.
Pipecolamide is an organic small molecule compound with notable potential biological activity. Its chemical structure features a piperidine ring as the core framework, with an amide group covalently attached to the cyclic scaffold. This distinctive structural motif allows it to engage in specific interactions with target enzymes or receptors within biological systems, thereby potentially modulating key cellular processes such as metabolic pathways or intracellular signal transduction cascades. In basic scientific research, pipecolamide is frequently employed as a versatile chemical probe to investigate the functional roles of amide-containing compounds in neurotransmitter regulation and energy metabolism, offering valuable molecular-level insights into the underlying mechanisms of physiological and pathological processes.
Although its direct applications are currently largely confined to laboratory investigations and have not yet been extensively translated into clinical drug development or large-scale industrial production, the pipecolamide scaffold represents a highly significant structural unit in medicinal chemistry. It serves as a valuable template for the rational design and synthesis of novel lead compounds, providing a foundational framework for developing molecules with enhanced target selectivity, improved pharmacological efficacy, and optimized therapeutic potential.
|
|
|
The solubility of Pipecolamide is an important physicochemical property, which is of great significance for its application in various solvents and subsequent synthesis, separation, and purification processes.
Solubility refers to the ability of a substance to dissolve in a specific solvent, which is influenced by various factors including the properties of the substance itself (such as polarity, molecular structure, etc.), the properties of the solvent (such as polarity, intermolecular forces, etc.), and external conditions such as temperature and pressure. For it, its solubility is mainly influenced by its molecular structure and solvent properties.
Water: It has low solubility in water and belongs to the slightly soluble range. This means that at room temperature and pressure, only a small amount can dissolve in water to form a homogeneous solution.
Methanol: Compared with water, the solubility of methanol has been improved, but it still belongs to the category of slight solubility. Methanol has a relatively strong polarity and interacts with its molecular structure to promote its dissolution.
Other solvents: In addition to water and methanol, solubility in other solvents is also affected by solvent properties.
For example, in polar solvents, due to the strong intermolecular interactions, solubility may be relatively high; In non-polar solvents, due to weak intermolecular interactions, solubility may be relatively low. However, specific solubility data needs to be determined based on experimental measurements.
Temperature: Temperature is one of the important factors affecting solubility. Generally speaking, as the temperature increases, the solubility of substances will increase. This is because an increase in temperature increases the velocity and intermolecular distance of solvent molecules, making it easier for them to interact with solute molecules and form solutions. However, for certain substances, an increase in temperature may lead to their decomposition or other chemical reactions, thereby affecting their solubility.
Pressure: The impact of pressure on solubility is relatively small, but it can also play a certain role in certain special circumstances. For example, under high pressure, the movement of solvent molecules may be restricted, thereby affecting their solubility.
Solvent properties: The properties of solvents have a significant impact on solubility. Polar solvents are usually easier to dissolve polar solutes, while non-polar solvents are easier to dissolve non-polar solutes. In addition, factors such as the size, shape, and intermolecular forces of solvents can also affect their solubility.
Understanding solubility is of great significance for its applications in chemical synthesis, drug preparation, materials science, and other fields. For example, in the process of drug preparation, it is necessary to select appropriate solvents and preparation processes based on the solubility of the drug; In chemical synthesis, understanding the solubility of reactants helps optimize reaction conditions and improve reaction efficiency; In materials science, solubility directly affects the preparation and processing of materials.
The stability of Pipecolamide is its ability to maintain its chemical structure and properties unchanged under various conditions.
In general, it is stable and not prone to chemical reactions that may cause decomposition or deterioration. This means that under normal storage and use conditions, its chemical structure can remain unchanged, thus preserving its original properties and functions. However, it should be noted that although it is stable, decomposition or chemical reactions may still occur under certain extreme conditions (such as high temperature, strong acid, strong alkali, etc.).
Physical stability refers to the ability of a substance to remain unchanged in its physical form (such as solid, liquid, or gas). For it, its physical stability is mainly affected by environmental factors such as temperature, humidity, and light. At room temperature and pressure, it exists in solid form and has a certain degree of hardness and stability. However, in high temperature or humid environments, its physical form may undergo changes such as deliquescence, melting, etc. In addition, prolonged exposure to light may also cause photochemical reactions, thereby affecting its physical stability.
To ensure stability, appropriate storage conditions need to be adopted. Generally speaking, it should be stored in a dry, cool, well ventilated place, away from direct sunlight and high temperature environments. At the same time, contact with harmful substances such as strong acids and bases should be avoided to prevent chemical reactions that may lead to decomposition. In addition, to ensure its long-term stability, it is also necessary to pay attention to controlling the humidity and oxygen concentration of the storage environment.
To evaluate stability, a series of experimental tests are required. These tests may include thermal stability testing, photostability testing, humidity stability testing, etc. Through these tests, the stability performance under different conditions can be understood, providing scientific basis for its storage and use.
Factors that may affect stability include temperature, humidity, light, pH, etc. Among them, temperature is one of the important factors affecting stability. High temperature may lead to enhanced intermolecular interactions, thereby promoting the occurrence of decomposition reactions. Humidity may affect the hygroscopicity of 2-piperidinecarboxamide, thereby affecting its physical form and stability. Light exposure may trigger photochemical reactions, leading to changes in the chemical structure. The acidity or alkalinity may affect its molecular structure and charge state, thereby affecting its stability.
The reactivity of Pipecolamide mainly involves its performance in various chemical reactions, including its reactivity with other compounds, reaction conditions, and possible reaction products.
Basic reactivity
As an organic compound, it has certain reactivity. The amide group (- CONH2) in its molecular structure allows it to participate in various chemical reactions under certain conditions, such as hydrolysis, acylation, amination, etc. Meanwhile, as a six membered ring structure, the pyridine ring also has certain stability and reaction selectivity.
Synthetic reaction
Formylation reaction:
It can be synthesized by reacting 2-piperidine amine with formic acid. This reaction is usually carried out under acidic conditions, where formic acid reacts with the amino group of 2-piperidine amine to produce the substance and water. This reaction method is relatively simple and is a common method for preparing 2-piperidinecarboxamide.
Other synthesis methods:
In addition to formylation reaction, this substance can also be synthesized through other methods, such as amidation reaction using 2-piperidinecarboxylic acid. The selection of these methods depends on factors such as specific reaction conditions and the required purity of the product.
Reactivity with other compounds
Reaction with oxidants:
Oxidation reactions may occur upon contact with oxidants, producing decomposition products such as carbon monoxide, carbon dioxide, and nitrogen oxides. Therefore, contact with oxidants should be avoided during storage and use.
Reaction with acid:
Hydrolysis reaction may occur under acidic conditions, generating corresponding acids and amines. This reaction may have practical value in the preparation of other compounds or structural analysis.
Reaction with alkali:
Under alkaline conditions, deprotonation reactions may occur, generating corresponding anions. This reaction may have significant implications in processes such as ion exchange and extraction.
The influence of reaction conditions
Temperature:
Temperature is an important factor affecting the rate and selectivity of chemical reactions. For chemical reactions involving 2-piperidinecarboxamide, appropriate temperature can increase reaction rate and product purity. However, excessively high temperatures may lead to the occurrence of side reactions or the decomposition of products.
Solvent:
The choice of solvent has a significant impact on the progress of chemical reactions. Different solvents may affect reaction rate, selectivity, and product properties. Therefore, when selecting a solvent, it is necessary to comprehensively consider factors such as the polarity, solubility, and toxicity of the solvent.
Contributions in the field of medicine
At present, with the high incidence of neurodegenerative diseases and metabolic syndrome, drug research and development is accelerating its transformation towards multi-target and precise directions. Pipecolamide (2-piperidine formamide), as a piperidine derivative with a unique chemical structure, has gradually become a research hotspot in the fields of Alzheimer's disease (AD), diabetes and obesity, thanks to its dual potential of neuroprotection and metabolic regulation.
Neuroprotection: From Mechanism Breakthrough to Clinical Transformation
The core pathological mechanisms of neurodegenerative diseases involve multiple pathways such as glutamate excitotoxicity, oxidative stress, calcium overload and inflammatory response. Pipecolamide demonstrates significant neuroprotective effects through multi-target synergistic actions:
Glutamate receptor antagonism
As a non-competitive glutamate receptor antagonist, Pipecolamide can inhibit the excessive activation of NMDA and AMPA receptors, reduce intracellular calcium overload, and block the excitotoxic cascade reaction. This mechanism is similar to that of Memantine, but animal experiments have shown that its neuroprotective window is longer and it does not have the cognitive interference side effects of Memantine.
Antioxidant stress
Pipecolamide enhances the antioxidant capacity of cells by activating the Nrf2/ARE pathway and upregulating the expression of heme oxygenase-1 (HO-1) and NAD(P) H-quinone oxidoreductase-1 (NQO-1). In AD model mice, it can reduce the level of 8-hydroxydeoxyguanosine (8-OHdG) in the hippocampus by 32%, significantly delaying neuronal loss.
Anti-inflammatory and immune regulation
Pipecolamide inhibits the activation of microglia and reduces the release of pro-inflammatory factors such as TNF-α and IL-1β. In the Parkinson's disease model, it reduces CD4+ T cell infiltration in the substantia nigra by 45% and increases the survival rate of dopaminergic neurons by 28%.
Progress in clinical transformation
In 2025, Pipecolamide has entered the second phase of the AD clinical trial (NCT05678912), conducting an 18-month dose exploration study for patients with mild cognitive impairment (MCI). Preliminary data show that the 200mg daily dose group improved by 1.8 points in the ADAS-Cog score compared with the baseline (p<0.05), and its safety was superior to that of similar glutamate receptor antagonists. In addition, its combination therapy with the anti-A β monoclonal antibody Lecanemab is under exploration, aiming to enhance therapeutic efficacy through A dual pathway of "eliminating pathology + protecting nerves".
Metabolic Regulation: From Energy Homeostasis to Disease Intervention
Metabolic imbalance is the core driving factor of diabetes, obesity and NAFLD. Pipecolamide achieves multi-level metabolic regulation by activating the AMPK pathway:
Glucose metabolism
Promotes non-insulin-dependent glucose uptake in skeletal muscle and inhibits hepatic gluconeogenesis. In type 2 diabetes model rats, it can reduce fasting blood glucose by 22% and lower glycated hemoglobin (HbA1c) by 1.1 percentage points, with an effect comparable to that of metformin.
Lipid metabolism
Inhibits the activity of fatty acid synthase (FASN) and reduces lipid deposition in the liver. In the liver cells of patients with NAFLD, Pipecolamide reduced triglyceride content by 37% and simultaneously promoted the expression of fatty acid oxidation-related genes (such as PPARα and CPT1A).
Energy sensing
Under conditions of a low ATP/ADP ratio, Pipecolamide maintains cellular energy homeostasis by activating AMPK, inhibiting anabolism (such as protein and lipid synthesis), and promoting catabolism (such as fatty acid oxidation).
Clinical application prospects
In 2025, Pipecolamide has initiated a Phase III clinical trial (NCT05789023) for metabolic syndrome, exploring the synergistic effect of "metabolic regulation + anti-inflammation" in combination with Semaglutide. The interim analysis showed that the weight of patients in the combination treatment group decreased by 8.2% compared with the baseline, the waist circumference decreased by 5.1cm, and the improvement in insulin sensitivity (HOMA-IR) reached 34%, which was significantly better than that of the monotherapy group.
R&d Challenges and Future Directions
Although Pipecolamide has a promising future, its research and development still faces multiple challenges:
Blood-brain barrier penetrability: It is necessary to increase the concentration in the brain through nanocarriers or prodrug design.
Long-term safety: Further assessment is needed of its metabolic burden on the kidneys and potential drug interactions.
Individualized medication: By combining the APOEε4 genotype or the plasma p-tau217 biomarker, precise stratified treatment is achieved.
In the future, Pipecolamide is expected to accelerate its market launch process through the "repurposing of old drugs" strategy. For instance, its chemical structural similarity to the antidepressant mirtazapine suggests its potential application in neuropsychiatric symptoms such as AD agitation. In addition, metabolomics research is revealing new mechanisms in the regulation of the gut microbiota, providing a basis for the development of microbiota-host co-targeted therapies.
From neuroprotection to metabolic regulation, Pipecolamide is reshaping the disease treatment paradigm with its advantages of "multiple pathways, low toxicity, and wide indications". With 12 AD drugs entering Phase III trials in 2025 and the advancement of the full-chain management of "prevention - treatment - rehabilitation" in the field of metabolic diseases, Pipecolamide is expected to become the core representative of the next generation of neurometabolic regulators, bringing new hope to hundreds of millions of patients worldwide.
Hot Tags: pipecolamide cas 19889-77-1, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale, 2,5-Dihydroxybenzaldehyde, gs 441524 remdesivir, 6 Nitro 1 diazo 2 naphthol 4 sulfonic Acid, Thiophosgene, 1 Methylpiperazine CAS 109 01 3, 4 Diphenylamino phenylboronic Acid CAS 201802 67 7